MicroRNA‐338‐3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression

BACKGROUND: The development of cardiac fibrosis involves the activation of cardiac fibroblasts (CFs) and their differentiation into myofibroblasts, which leads to the disruption of the extracellular matrix network. In the past few years, microRNAs (miRNA) have been described as potential targets for...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Cheng, Wang, Rui, Lu, Jianjun, He, Yongli, Wu, Yueheng, Ma, Wuxia, Xu, Jindong, Wu, Zejia, Feng, Zhe, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396162/
https://www.ncbi.nlm.nih.gov/pubmed/35792028
http://dx.doi.org/10.1002/jcla.24584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396162/
https://www.ncbi.nlm.nih.gov/pubmed/35792028
http://dx.doi.org/10.1002/jcla.24584

Ejemplares similares